References
- Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, Le Souef P, et al. International Consensus on (ICON) pediatric asthma. Allergy 2012;67:976–997
- Claesson HE, Dahlen SE. Asthma and leukotrienes: antileukotrienes as novel antiasthmatic drugs. J Intern Med 1999;245:205–227
- Cai C, Yang J, Hu S, Zhou M, Guo W. Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma. Lung 2007;185:105–112
- Schultz A, Brand P. Episodic viral wheeze and multiple trigger wheeze in preschool children: a useful distinction for clinicians? Paediatr Respir Rev 2011;12:160–164
- Hunt J. Exhaled breath condensate: an evolving tool for non-invasive evaluation of lung disease. J Allergy Clin Immunol 2002;110:28–34
- Rabinovitch N, Reisdorph N, Silveira L, Gelfand EW. Urinary leukotriene E4 levels identify children with tobacco smoke exposure at risk for asthma exacerbation. J Allergy Clin Immunol 2011;128:323–327
- Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002;53:477–498
- Beckett PA, Howarth PH. Pharmacotherapy and airway remodelling in asthma? Thorax 2003;58:163–174
- Lazarus SC. Clinical practice. Emergency treatment of asthma. N Engl J Med 2010;363:755–764
- WHO. World Health Organization Fact Sheet Fact sheet No. 307: Asthma. 2009
- Braman SS. The global burden of asthma. Chest 2006;130:4S–12S
- Global Initiative for Asthma. 2009. GINA report: Global Strategy for Diagnosis and Management of Asthma in Children 5 years and younger, page-7 URL: http://www.ginasthma.org. (Bisgaard H, Nielsen KG. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med 2000;162:187-90)
- Fanta CH. Asthma. N Engl J Med 2009;360:1002–1014
- Global Initiative for Asthma. 2009. GINA report: Global Strategy for Diagnosis and Management of Asthma in Children 5 years and younger, page-7. URL: http://www.ginasthma.org. (Knorr B, Franchi LM, Bisgaard H, Vrmeulen JH, LeSouef P, Santanello N, Michele TM, et al. Montelukast, a leukotriene receptor antagonist for the treatment of persistent asthma in children aged 2-5 years. Pediatrics 2001;108E48)
- Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG, Hunt JF. Asthma outcomes: biomarker. J Allergy Clin Immunol 2012;129:S9–S23
- Hallstrand TS, Chi EY, Singer AG, Gelb MH, Henderson WR. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2007;176:1072–1078
- Montuschi P. Role of leukotrienes and leukotriene modifiers in asthma. Pharmaceuticals 2010;3:1792–1811
- Atkinson AJ, Colburn W, DeGruttola V, DeMets D, Downing G, Hoth D, Oates J, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89–95
- Brockmann PE, Castro-Rodriguez JA, Holmgren NL, Cerda J, María Contreras A, Moya A, Bertrand PJ. Urinary leukotriene excretion profile in children with exercise-induced asthma compared with controls: a preliminary study. Allergol Immunopathol (Madr) 2012;40:181–186
- Bacharier LB, Boner A, Carlsen K, Eigenmann PA, Frischer T, Gotz M, Helms PJ, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5–34
- Montuschi P, Sala A, Dahlén S-E, Folco G. Pharmacological modulation of the leukotriene pathway in allergic airway disease. Drug Discov Today 2007;12:404–412
- Davidson AB, Lee TH, Scanlon PD, Solway J, McFadden ER Jr, Ingram RH Jr. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. Am Rev Respir Dis 1987;135:333–337
- Rabinovich N. Urinary leukotriene E4. Immunol Allergy Clin North A 2007;27:651–664
- Bisgaard H. Montelukast in RSV – bronchiolitis. Am J Resp Crit Car Med 2004;169:542–543
- Piedimonte G, Renzetti G, Auais A, Di Marco A, Tripodi S, Colistro F, Villani A. Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy. Pediatr Pulmonol 2005;40:285–291
- Xepapadaki P, Papadopoulos NG, Bossios A, Manoussakis T, Saxoni-Papageorgiou P. Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy. J Allergy Clin Immunol 2005;116:299–304
- Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271–277